Richard A. Miller M.D., President and CEO at Corvus Pharmaceuticals, Inc. (CRVS), bought 12,000 shares at $3.52 ($41K) on 2019-06-13, disclosed to the SEC on 2019-06-17.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.52 | 343 | $1K | 3.0% |
| 2 | $3.40 | 11,657 | $40K | 97.0% |
| Total | $3.40 avg | 12,000 | $41K | 100% |
| Filing → |
| CRVS | BUY | 2022-12-15 | $45K | — | Filing → |
| CRVS | BUY | 2022-09-28 | $19K | — | Filing → |
| CRVS | BUY | 2022-09-20 | $16K | — | Filing → |